Literature DB >> 18093542

Cryoglobulins as indicators of upregulated immune response in schizophrenia.

Anna Boyajyan1, Aren Khoyetsyan, Gohar Tsakanova, Robert B Sim.   

Abstract

OBJECTIVE: In the present work the concentration of abnormal immune complexes, cryoglobulins (Cgs), in the blood of schizophrenic patients was determined, and immunochemical composition of these complexes was studied. PATIENTS AND METHODS: Eighty multiple-episode schizophrenia-affected subjects (55 medicated, 25 drug-free) and 40 healthy controls were involved in the study. Cgs were isolated by exposure of blood serum samples to precipitation at low temperature followed by extensive washings of Cg-enriched pellets. The immunochemical composition of Cgs was analyzed using different electrophoretic and immunoblotting systems.
RESULTS: Significantly increased blood serum levels of type III Cgs were detected in all schizophrenia-affected subjects, as compared to controls. We also revealed the presence of C1q and C3 complement proteins and their activation products in Cgs isolated from the blood of schizophrenic patients.
CONCLUSIONS: The results of the present study suggest that Cgs are involved in schizophrenia-associated upregulated immune response by binding the complement proteins, activating the complement cascade and triggering aberrant apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093542     DOI: 10.1016/j.clinbiochem.2007.11.014

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Association of C1QB gene polymorphism with schizophrenia in Armenian population.

Authors:  Roksana Zakharyan; Aren Khoyetsyan; Arsen Arakelyan; Anna Boyajyan; Anaida Gevorgyan; Anna Stahelova; Frantisek Mrazek; Martin Petrek
Journal:  BMC Med Genet       Date:  2011-09-28       Impact factor: 2.103

2.  Immunochemical composition of cryoglobulins generated in stroke.

Authors:  Levon Manukyan; Anna Boyajyan; Arsen Arakelyan; Violetta Ayvazyan; Elina Arakelova; Robert Sim; George Grigoryan
Journal:  J Clin Immunol       Date:  2008-11-04       Impact factor: 8.317

Review 3.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

Review 5.  The complement system in schizophrenia: where are we now and what's next?

Authors:  Julia J Woo; Jennie G Pouget; Clement C Zai; James L Kennedy
Journal:  Mol Psychiatry       Date:  2019-08-22       Impact factor: 15.992

Review 6.  Gastroenterology issues in schizophrenia: why the gut matters.

Authors:  Emily G Severance; Emese Prandovszky; James Castiglione; Robert H Yolken
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

8.  Maternal complement C1q and increased odds for psychosis in adult offspring.

Authors:  Emily G Severance; Kristin L Gressitt; Stephen L Buka; Tyrone D Cannon; Robert H Yolken
Journal:  Schizophr Res       Date:  2014-09-04       Impact factor: 4.939

9.  Cryoglobulins as potential triggers of inflammation in schizophrenia.

Authors:  Andranik Chavushyan; Meri Hovsepyan; Anna Boyajyan
Journal:  Schizophr Res Treatment       Date:  2013-12-15

Review 10.  Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Authors:  Emily G Severance; Faith B Dickerson; Robert H Yolken
Journal:  Pharmacol Ther       Date:  2018-05-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.